529 related articles for article (PubMed ID: 22029756)
1. Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
Schröder FH
N Engl J Med; 2011 Nov; 365(21):1953-5. PubMed ID: 22029756
[No Abstract] [Full Text] [Related]
2. Prostate-cancer screening--what the U.S. Preventive Services Task Force left out.
Brett AS; Ablin RJ
N Engl J Med; 2011 Nov; 365(21):1949-51. PubMed ID: 22029759
[No Abstract] [Full Text] [Related]
3. One man at a time--resolving the PSA controversy.
McNaughton-Collins MF; Barry MJ
N Engl J Med; 2011 Nov; 365(21):1951-3. PubMed ID: 22029758
[No Abstract] [Full Text] [Related]
4. Comment on the US Preventive Services Task Force's draft recommendation on screening for prostate cancer.
Kwiatkowski M; Klotz L; Hugosson J; Recker F
Eur Urol; 2012 Apr; 61(4):851-4. PubMed ID: 22285762
[No Abstract] [Full Text] [Related]
5. The United States Preventive Services Task Force recommendation against prostate-specific antigen screening--point.
Ablin RJ
Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):391-4. PubMed ID: 22315362
[No Abstract] [Full Text] [Related]
6. The Society of Urologic Oncology's reply to the US Preventative Services Task Force's recommendation on PSA testing.
Messing EM; Albertsen P; Andriole GL; Carroll PR; Klein EA
Urol Oncol; 2012; 30(1):117-9. PubMed ID: 22243597
[No Abstract] [Full Text] [Related]
7. Screening for prostate cancer: commentary on the recommendations of the Canadian Task Force on the Periodic Health Examination. The U.S. Preventive Services Task Force.
Am J Prev Med; 1994; 10(4):187-93. PubMed ID: 7528518
[No Abstract] [Full Text] [Related]
8. Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation.
Cohn JA; Wang CE; Lakeman JC; Silverstein JC; Brendler CB; Novakovic KR; McGuire MS; Helfand BT
Urol Oncol; 2014 Jan; 32(1):41.e23-30. PubMed ID: 23911680
[TBL] [Abstract][Full Text] [Related]
9. Psychological research and the prostate-cancer screening controversy.
Arkes HR; Gaissmaier W
Psychol Sci; 2012 Jun; 23(6):547-53. PubMed ID: 22555966
[TBL] [Abstract][Full Text] [Related]
10. Grading the new US Preventive Services Task Force prostate cancer screening recommendation.
Volk RJ; Wolf AM
JAMA; 2011 Dec; 306(24):2715-6. PubMed ID: 22203540
[No Abstract] [Full Text] [Related]
11. 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.
Prasad SM; Drazer MW; Huo D; Hu JC; Eggener SE
JAMA; 2012 Apr; 307(16):1692-4. PubMed ID: 22535850
[No Abstract] [Full Text] [Related]
12. Prostate-specific antigen testing: men's responses to 2012 recommendation against screening.
Squiers LB; Bann CM; Dolina SE; Tzeng J; McCormack L; Kamerow D
Am J Prev Med; 2013 Aug; 45(2):182-9. PubMed ID: 23867025
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy.
Hoffman KE; Nguyen PL; Ng AK; D'Amico AV
J Urol; 2010 May; 183(5):1798-802. PubMed ID: 20299039
[TBL] [Abstract][Full Text] [Related]
14. Screening for prostate cancer among men 75 years of age or older.
Barry MJ
N Engl J Med; 2008 Dec; 359(24):2515-6. PubMed ID: 19073973
[No Abstract] [Full Text] [Related]
15. What the U.S. Preventive Services Task Force missed in its prostate cancer screening recommendation.
Catalona WJ; D'Amico AV; Fitzgibbons WF; Kosoko-Lasaki O; Leslie SW; Lynch HT; Moul JW; Rendell MS; Walsh PC
Ann Intern Med; 2012 Jul; 157(2):137-8. PubMed ID: 22801676
[No Abstract] [Full Text] [Related]
16. The pendulum swings back: Screening for prostate cancer in 2018.
Thompson IM
Cancer; 2018 Jul; 124(13):2690-2692. PubMed ID: 29786846
[No Abstract] [Full Text] [Related]
17. Summaries for patients. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med; 2012 Jul; 157(2):I-44. PubMed ID: 22801691
[No Abstract] [Full Text] [Related]
18. Summaries for patients. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
Ann Intern Med; 2013 May; 158(10):I-28. PubMed ID: 23567761
[No Abstract] [Full Text] [Related]
19. PSA test not recommended by Canadian Task Force.
Tanday S
Lancet Oncol; 2014 Dec; 15(13):e589. PubMed ID: 25499287
[No Abstract] [Full Text] [Related]
20. Risk factors, prevention and early detection of prostate cancer.
Loeb S; Schaeffer EM
Prim Care; 2009 Sep; 36(3):603-21. PubMed ID: 19616157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
